#self-monitoring blood glucose device market share

[renubresearch]

Self-Monitoring Blood Glucose Device Market will be US$ 21.05 Billion by 2032

Self-Monitoring Blood Glucose Device Market Size The market for self-monitoring blood glucose devices is projected to reach US$ 21.05 billion by 2032, up from US$ 11.68 billion in 2023, with a CAGR of 6.76% from 2024 to 2032. Monitoring your blood glucose levels is a crucial part of managing diabetes. It helps people with diabetes and their healthcare providers to keep their blood sugar levels…

[marketstudyreport]

Digital Diabetes Management Market Share and Specification forecast To 2030

The global digital diabetes management market reached a value of USD 11.8 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030. This strong growth is largely driven by the rising global prevalence of diabetes, as well as continuous advancements in digital technology and innovative solutions for disease management. According to the International Diabetes Federation, there were approximately 537 million adults with diabetes in 2021, and this number is expected to increase to 783 million by 2045. As digital technology evolves, the diabetes management market is anticipated to see a wave of innovations, potentially transforming the way patients and healthcare providers address diabetes.

One major component of this transformation is the rapid increase in smartphone apps designed for diabetes management. These apps, available on various web-based app stores, allow patients to monitor blood glucose levels, track dietary intake, and manage other health metrics. Over a hundred of these apps are now available, indicating strong demand for digital solutions that support patients in self-monitoring and managing their condition.

Gather more insights about the market drivers, restrains and growth of the Digital Diabetes Management Market

The rise in diabetes cases worldwide is also linked to changing lifestyle factors, such as smoking and increased alcohol consumption. Obesity, a significant risk factor for diabetes, is also contributing to this growing population of diabetes patients. The increased awareness of the benefits of diet and weight management apps is showing promise for the digital diabetes management market. These apps provide tools to manage weight and dietary intake, offering support for lifestyle adjustments critical in diabetes care.

Diabetes is a chronic condition where the body either cannot produce enough insulin or cannot effectively use the insulin it produces, leading to elevated blood glucose levels. People with diabetes often struggle to manage daily aspects of their condition, such as dietary choices, interpreting medical information, and understanding the effects of physical activity on blood sugar. Digital technologies help bridge these gaps by enabling real-time communication between patients and healthcare providers, allowing data exchange for better-informed decision-making. This has led to the development of a digital ecosystem that leverages data-driven tools to improve diabetes treatment outcomes.

The COVID-19 pandemic further underscored the importance of digital diabetes management tools. Managing blood glucose levels became essential for COVID-19 patients with diabetes, as medications for COVID-19 could alter glucose levels. The Centers for Disease Control and Prevention (CDC) reported that people with diabetes who contracted COVID-19 had a higher likelihood of requiring critical care. As a result, there was a surge in demand for diabetes management devices during the pandemic to help monitor and regulate blood sugar levels in patients more closely.

End-use Segmentation Insights:

The digital diabetes management market is divided into end-use segments, including hospitals, home settings, and diagnostic centers. In hospitals, digital platforms and mobile apps are used to provide education on diabetes, offer self-management tools, and give ongoing support to patients. These digital tools help patients better understand their condition, monitor blood glucose, manage medications, and receive advice from healthcare professionals, ultimately improving patient engagement and health outcomes.

At home, patients increasingly use digital devices such as glucometers, continuous glucose monitors (CGMs), and insulin pumps. These devices allow for convenient self-monitoring and have driven demand as more patients prefer managing their condition within their daily environment. Additionally, larger diagnostic centers are offering specialized digital diabetes management services. These centers provide individualized care plans, prescribe appropriate devices, and offer consultations, enhancing patient care and providing comprehensive diabetes management in a digital format.

Overall, the digital diabetes management market is set to grow as digital tools become more integrated into diabetes care, providing patients with greater flexibility, access to information, and support in managing their health effectively.

Order a free sample PDF of the Digital Diabetes Management Market Intelligence Study, published by Grand View Research.

[harshnews]

Mobile Health (mhealth) Solutions Market Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus

"Mobile Health (mhealth) Solutions Market – Industry Trends and Forecast to 2029

Global Mobile Health (mhealth) Solutions Market, By Connected Devices (Glucose and Blood Pressure Monitor, Peak Flow Meter, Pulse Oximeter), Apps (Weight Loss, Women Health, Diabetes Management, Mental Health), Services (Remote Monitoring, Consultation) – Industry Trends and Forecast to 2029

Access Full 350 Pages PDF Report @

**Segments**

- **Service Type**: The mHealth solutions market can be segmented based on service type into monitoring services, diagnostic services, treatment services, wellness and prevention services, and others. Monitoring services include wearable devices and mobile apps for tracking health metrics. Diagnostic services encompass remote consultations and virtual diagnostics. Treatment services involve telemedicine and teleconsultation for medical treatment. Wellness and prevention services focus on fitness apps, diet trackers, and mental health support.

- **Platform**: Based on platform, the market can be categorized into mobile apps and web-based solutions. Mobile apps are designed for smartphones and tablets, offering convenience and accessibility to users. Web-based solutions are accessed through internet browsers on various devices, providing a wider reach and compatibility across different platforms.

- **End-User**: The mHealth solutions market can also be segmented by end-user, including healthcare providers, patients, and healthcare payers. Healthcare providers utilize mHealth solutions for remote patient monitoring, telemedicine consultations, and electronic health records management. Patients benefit from mHealth apps for self-care, medication reminders, and accessing medical information. Healthcare payers use mHealth solutions for claims processing, insurance management, and data analytics.

**Market Players**

- **Apple Inc.**: Apple is a prominent player in the mHealth solutions market with offerings like the Health app and Apple Watch, which enable users to track health data and access medical information conveniently.

- **Google LLC**: Google's mHealth initiatives include Google Fit for fitness tracking, and partnerships with healthcare providers for data integration and telehealth services.

- **Fitbit, Inc.**: Fitbit specializes in wearable health devices that monitor fitness metrics, sleep patterns, and heart rate, catering to wellness and prevention services in the mHealth market.

- **Cerner Corporation**: Cerner provides healthcare technology solutions including electronic health records (EHR) and telemedicine platforms, supporting healthcare providers in delivering mHealth services.

- **Zoetis Inc.**: Zoetis focuses on mHealth solutionsZoetis Inc. is a key player in the mHealth solutions market, primarily focusing on providing innovative solutions for the healthcare industry. As a leading animal health company, Zoetis leverages its expertise to develop mHealth tools tailored to veterinary professionals, pet owners, and livestock producers. The company's commitment to advancing animal health through technology has positioned it as a significant contributor to the evolution of mHealth applications in the veterinary sector.

Zoetis' mHealth solutions encompass a wide range of offerings aimed at improving the well-being of animals and enhancing the efficiency of veterinary care. Through the development of mobile apps, wearable devices, and data analytics platforms, Zoetis empowers veterinarians to monitor animal health, track medication schedules, and streamline communication with pet owners. These tools not only facilitate remote monitoring and teleconsultations but also enable real-time access to critical health information, leading to more proactive and personalized veterinary care.

In addition to serving the veterinary community, Zoetis caters to pet owners seeking convenient and reliable ways to manage their pets' health and wellness. By providing user-friendly mobile apps for tracking vaccination records, scheduling appointments, and receiving personalized care recommendations, Zoetis enhances the overall pet ownership experience. This direct engagement with end-users fosters stronger relationships between pet owners and veterinarians, ultimately leading to better health outcomes for companion animals.

Furthermore, Zoetis recognizes the importance of mHealth solutions in the agricultural sector, where the health and productivity of livestock play a crucial role in food production systems. Through digital platforms that enable remote monitoring of livestock health, disease surveillance, and herd management, Zoetis empowers livestock producers to make informed decisions that optimize animal welfare and farm productivity. By leveraging data-driven insights and predictive analytics, Zoetis equips livestock producers with the tools necessary to mitigate disease outbreaks, improve breeding practices, and ensure sustainable agricultural practices.

Overall, Zoetis' dedication to advancing mHealth solutions for the veterinary and livestock industries underscores its commitment**Global Mobile Health (mHealth) Solutions Market Analysis:**

- **Connected Devices**: The mHealth solutions market is witnessing significant growth in connected devices segment, including glucose and blood pressure monitors, peak flow meters, and pulse oximeters. These devices empower users to track vital health metrics in real-time, enabling proactive health management and remote monitoring capabilities.

- **Apps**: The market is also driven by a diverse range of mHealth apps catering to specific health needs such as weight loss, women's health, diabetes management, and mental health. These apps provide users with personalized health solutions, including fitness tracking, symptom management, medication reminders, and virtual consultations, contributing to the continued expansion of the mHealth market.

- **Services**: Remote monitoring and consultation services are key components of the mHealth solutions market, offering healthcare providers and patients with seamless connectivity and access to healthcare resources. The adoption of telemedicine platforms and remote monitoring tools has surged, allowing for efficient healthcare delivery, improved patient outcomes, and cost-effective healthcare solutions.

The global mHealth solutions market is forecasted to experience robust growth driven by the increasing prevalence of chronic diseases, rising adoption of smartphones and wearable devices, and growing demand for remote healthcare services. Technological advancements in connected devices and apps, coupled with the expansion of telemedicine services, are expected to fuel market growth further. Additionally, the emphasis on preventive healthcare and wellness initiatives is shaping the mHealth landscape, with a focus on personalized health solutions and patient-centric care models.

The market

Table of Contents: Mobile Health (mhealth) Solutions Market

1 Introduction

2 Global Mobile Health (mhealth) Solutions Market Segmentation

3 Executive Summary

4 Premium Insight

5 Market Overview

6 Mobile Health (mhealth) Solutions Market, by Product Type

7 Mobile Health (mhealth) Solutions Market, by Modality

8 Mobile Health (mhealth) Solutions Market, by Type

9 Mobile Health (mhealth) Solutions Market, by Mode

10 Mobile Health (mhealth) Solutions Market, by End User

12 Mobile Health (mhealth) Solutions Market, by Geography

12 Mobile Health (mhealth) Solutions Market, Company Landscape

13 Swot Analysis

14 Company Profiles

Countries Studied:

North America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)

Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)

Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)

Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Objectives of the Report

To carefully analyze and forecast the size of the Mobile Health (mhealth) Solutions market by value and volume.

To estimate the market shares of major segments of the Mobile Health (mhealth) Solutions

To showcase the development of the Mobile Health (mhealth) Solutions market in different parts of the world.

To analyze and study micro-markets in terms of their contributions to the Mobile Health (mhealth) Solutions market, their prospects, and individual growth trends.

To offer precise and useful details about factors affecting the growth of the Mobile Health (mhealth) Solutions

To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Mobile Health (mhealth) Solutions market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Browse Trending Reports:

Mhealth Solutions Market Telecom Cloud Billing Market Industrial Cooking Fire Protection Systems Market Food Manufacturing Market Natural Surfactant Market Industrial Networking Solutions Market Facility Management Market Cathode Materials Market High Purity Gases Market Cassava Starch Market Embedded Connectivity Solutions Market Central Fill Pharmacy Automation Market Rfid In Healthcare Market Virtual Pipeline Systems Market Fiberoptic Phototherapy Equipment Market Suture Passer Market Baby Apparel Market Peanut Allergy Treatment Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[industrynewsupdates]

Digital Diabetes Management Market Growth Trends and Strategies, 2030

The global digital diabetes management market size is expected to reach USD 21.9 billion by 2030, expanding at a CAGR of 8.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth are the growing incidences of diabetes globally, the increasing number of product launches, and innovation in technologies such as predictive analytics and artificial intelligence (AI). 

Data analytics and artificial intelligence are now an integral part of digital solutions for diabetics. AI is gaining rapid attention due to its ability to harness massive volumes of patient information. Digital diabetes management tools help patients analyze their glucose levels and pattern. They also help patients decide on food intake and dosage of insulin. The number of smartphone apps for disease management has seen a monumental rise over the past few years, giving the market a major boost. For instance, in September 2019, Abbott entered into a non-exclusive partnership with Sanofi to integrate cloud-connected insulin pens (Sanofi) with FreeStyle Libre mobile application (Abbott) to ease the management process of diabetes. 

Gather more insights about the market drivers, restrains and growth of the Digital Diabetes Management Market

Detailed Segmentation:

Product Insights

The continuous blood glucose monitoring system segment held the largest revenue share of over 40.6% in 2022, owing to its advanced features such as compatibility with smart devices that serve as display devices. Moreover, it can be set to send custom alerts to patients when certain glucose thresholds are reached. Based on products, the market has been segmented into smart insulin pens, continuous blood glucose monitoring systems, smart glucose meters, smart insulin pumps, and apps. Diabetes management apps are divided into digital diabetes management apps and weight & diet management apps.

End-use Insights

Based on end-use, the digital diabetes management market is segmented into hospitals, home settings, and diagnostic centers. Hospitals can use digital platforms or mobile apps that provide diabetes education, self-management tools, and support, as well as offer them to patients. With these technologies, patients may better understand their condition, monitor their blood sugar levels, take control of their medication, and get advice from medical specialists.

Type Insights

The wearable devices segment held the largest revenue share of 56.9% in 2022, and the segment is expected to expand at the fastest CAGR of 8.4% over the forecast period. The segment's growth is majorly attributed to technological advancements such as the advent of artificial intelligence, the launch of new products such as closed-loop pump systems and smart insulin patches, and the growing adoption of self-insulin delivery devices in diabetes management. The market is segmented based on type into wearable devices and handheld devices.

Regional Insights

North America led the market in 2022 with a revenue share of over 38.0%, aided by the availability of advanced technologies and the recent approval of many digital blood glucose patient monitoring devices in the region. For instance, in January 2022, Insulet Corporation announced that it had received clearance from the U.S. FDA for its Omnipod 5 Automated Insulin Delivery System. It is a unique system that integrates with Dexcom G6 Continuous Glucose Monitoring (CGM). It facilitates remote patient monitoring and data transfer through the Omnipod 5 mobile app with its integrated SmartBolus Calculator. The increasing geriatric population and the growing burden of diabetes due to lifestyle changes are expected to boost regional market growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global artificial hip and knee joints market size was estimated at USD 12.57 billion in 2023 and is projected to grow at a CAGR of 2.85% from 2024 to 2030.

• The global breast shells market size was valued at USD 71.0 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2030. 

Key Companies & Market Share Insights

Major market players focus on adopting new technologies and introducing advanced products, taking advantage of important cooperation activities, and exploring acquisitions and government initiatives to offer their customers better services and strengthen their market presence. For instance, in August 2022, Abbott Laboratories announced its collaboration with WeightWatchers to launch new digital tools to emphasize the importance of weight loss and controlling blood sugar in diabetes patients. Abbott integrated its recent digital glucose monitoring technology into WeightWatchers' diabetes-specific program, as a part of this strategic partnership.

In another instance, in May 2021, Ascensia Diabetes Care launched a browser-based diabetes management and analytics platform, GlucoContro.online, that provides data-driven care for people who use any of the CONTOUR blood glucose monitoring meters. In September 2021, Ypsomed AG partnered with Dexcom, a market leader in CGM systems. This partnership was intended to make data from Dexcom G6 CGM devices available in the Ypsomed application in a smart device. 

Following are some of the major participants in the global digital diabetes management market:

• Abbott

• Medtronic

• F. Hoffmann-La Roche Ltd.

• Bayer AG

• Sanofi

• Dexcom, Inc.

• LifeScan, Inc.

• Insulet Corporation

• Ascensia Diabetes Care Holdings AG

• B. Braun Melsungen AG

Digital Diabetes Management Market Segmentation 

Grand View Research has segmented the global digital diabetes management market based on product, type, end-use, and region:

Digital Diabetes Management Product Outlook (Revenue, USD Million, 2018 - 2030)

• Smart Glucose Meter

• Continuous Blood Glucose Monitoring System

• Smart Insulin Pens

• Smart Insulin Pumps

• Apps

o Digital Diabetes Management Apps

o Weight & Diet Management Apps

Digital Diabetes Management Type Outlook (Revenue, USD Million, 2018 - 2030)

• Wearable Devices

• Handheld Devices

Digital Diabetes Management End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Home settings

• Diagnostic centers

Digital Diabetes Management Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Sweden

o Norway

o Denmark

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE 

o Kuwait

Order a free sample PDF of the Digital Diabetes Management Market Intelligence Study, published by Grand View Research.

[adityarana1687-blog]

Southeast Asia Diabetes Devices Market To Reach $3.58 Billion By 2030

The Southeast Asia diabetes devices market size is anticipated to reach USD 3.58 billion by 2030, registering a CAGR of 9.36% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is growing due to the rising occurrence of diabetes linked to aging, obesity, and poor lifestyle choices. Obesity rates in SEA have surged by 40% from 1990 to 2013. Forecasts indicate that by 2030, over 52.4 million adults and 21 million youth in the region will be obese. As obesity rates continue to increase in the region, the incidence of diabetes is also expected to rise, driving the demand for effective diabetes management devices. The excessive body fat associated with obesity can lead to insulin resistance, a contributor to the onset of diabetes, further exacerbating the already high prevalence of the disease in Southeast Asia.

Diabetes devices play a pivotal role in enhancing the care and management of diabetic patients. The growing demand for these devices is driven by their ability to prevent prolonged hospital stays and reduce mortality rates among individuals with diabetes. The proactive approach enabled by diabetes devices can help prevent serious complications associated with uncontrolled blood sugar levels. By allowing for early detection of hypo- or hyperglycemia, these devices enable prompt action to stabilize glucose levels before they escalate into critical situations. This proactive monitoring can significantly reduce the risk of diabetic emergencies requiring hospitalization, ultimately improving patient outcomes and quality of life.

Increasing awareness about diabetes management through educational campaigns and programs plays a vital role in driving market growth. Educating patients about the importance of regular monitoring and adherence to treatment regimens boosts the demand for related medical devices. For instance, in April 2024, Embecta, a New Jersey company, launched a diabetes education program named emERGE in the Asia-Pacific region. The program is set to commence in 11 countries, including Singapore, Thailand, Vietnam, Australia, South Korea, Japan, Indonesia, Malaysia, the Philippines, and New Zealand. The primary goal of this initiative is to provide educational benefits to around 5,000 healthcare professionals, such as practitioners, diabetes nurse educators, and lead pharmacists, through a series of four interactive webinars.

Request a free sample copy or view report summary: Southeast Asia Diabetes Devices Market Report

Southeast Asia Diabetes Devices Market Report Highlights

In 2023, the insulin delivery devices segment dominated the market with a share of over 50.00% and is expected to grow over the forecast period due to patient preferences, treatment outcomes, and healthcare professional recommendations

Based on distribution channels, the hospital pharmacies segment held the largest share of around 53.00% in 2023. This can be attributed to the accessibility of hospital pharmacies to patients who visit healthcare facilities for various needs, including diabetes management

The retail pharmacies segment is expected to grow at the fastest CAGR during the forecast period due to the expanding network of retail pharmacies in the region

The hospital pharmacy end use segment held a majority share of the market of over 40.00% in 2023. This is attributed to the number of patients with diabetes being hospitalized

The diagnostic centers segment is expected to grow at the fastest CAGR over the forecast period due to their ability to provide quick and accurate results

Southeast Asia Diabetes Devices Market Segmentation

Grand View Research has segmented the Southeast Asia diabetes devices market based on type, distribution channel, end-use, and country: 

SEA Diabetes Devices Type Outlook (Revenue, USD Million, 2018 - 2030)

BGM Devices

Self-Monitoring Devices

Blood Glucose Meter

Testing Strips

Lancets

Continuous Glucose Monitoring Devices

Sensors

Transmitter

Receiver

Insulin Delivery Devices

Pens

Pumps

Syringes

Jet Injector

SEA Diabetes Devices Distribution Channel (Revenue, USD Million, 2018 - 2030)

Hospital Pharmacies

Retail Pharmacies

Diabetes Clinics/Centers

Online Pharmacies

Others

SEA Diabetes Devices End Use Outlook (Revenue, USD Million; 2018 - 2030)

Hospitals

Diagnostic Centers

Homecare

Southeast Asia Diabetes Devices Country Outlook (Revenue, USD Million; 2018 - 2030)

Indonesia

Thailand

Philippines

Malaysia

Vietnam

Myanmar

Singapore

Rest of SEA

List of Key Players in the Southeast Asia Diabetes Devices Market

Abbott Laboratories

Arkray, Inc.

B Braun Melsungen AG

Bayer AG

Companion Medical

Dexcom Inc.

F.Hoffmann-La-Ltd.

Insulet Corporation

Lifescan, Inc.

Medtronic plc

Novo Nordisk

Sanofi

Valeritas Holding Inc.

Ypsomed Holdings

[tamanna31]

Insulin Delivery Devices Market Size, Share, Growth, Analysis Forecast to 2030

Insulin Delivery Devices Industry Overview

The global insulin delivery devices market size was estimated at USD 16.43 billion in 2023 and is expected to grow at a CAGR of 7.89% from 2024 to 2030.

The surge in market growth is largely attributed to the rising global prevalence of diabetes, which has heightened the demand for advanced and user-friendly solutions for diabetes management. Technological advancements play a crucial role in the market growth, with the development of devices that are more effective, less invasive, and tailored to meet patients' individual needs.

Furthermore, integrating digital technology with insulin delivery devices is expected to boost market growth. This includes the rise of Continuous Glucose Monitoring (CGM) systems that work in tandem with insulin delivery devices to provide real-time glucose monitoring and automated insulin adjustments.

Gather more insights about the market drivers, restrains and growth of the Insulin Delivery Devices Market

Technological advancements in diabetes management have significantly transformed insulin delivery methods, evolving from traditional injections to more advanced, minimally invasive techniques. Initially, insulin administration faced challenges in maintaining consistent blood glucose levels. However, the advent of insulin pens facilitated easier self-administration, reducing discomfort. The development of insulin pumps allowed for continuous insulin infusion, enhancing glucose control. A pivotal advancement was the introduction of Continuous Glucose Monitoring (CGM) devices, providing real-time glucose data, essential for informed decision-making. This set the stage for Artificial Pancreas Systems (APS), which integrate CGM data with insulin pumps for automated delivery, closely mimicking natural pancreatic function. Bionic technology, blending biological and artificial processes, has been instrumental in advancing insulin delivery. It underpins devices such as APS, utilizing algorithms, sensors, and automated pumps for precise blood sugar regulation, minimizing manual intervention. These innovations offer tailored, user-friendly solutions, notably improving patient outcomes. Modern insulin pumps, equipped with CGM integration, predictive algorithms, and smartphone connectivity, exemplify significant progress in device functionality, offering accurate and adaptable insulin management. These features not only mitigate risks associated with blood glucose extremes but also empower users with finer control over their insulin dosing, responding dynamically to glucose level changes.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global nucleic acid therapeutics CDMO market size was estimated at USD 13.53 billion in 2023 and is projected to grow at a CAGR of 14.10% from 2024 to 2030. 

The global PET scanners market size was valued at USD 2.64 billion in 2023 and is projected to grow at a CAGR of 3.65% from 2024 to 2030.

Key Insulin Delivery Devices Company Insights

The insulin delivery devices market is a dynamic and rapidly evolving segment within the medical device industry, primarily driven by the increasing prevalence of diabetes globally. This market includes a range of devices designed to administer insulin to diabetic patients, aiming to maintain their blood glucose levels. As diabetes management shifts towards more patient-friendly, efficient, and less invasive methods, the demand for innovative insulin delivery devices has surged. The insulin delivery devices market is highly competitive, with companies continuously innovating and expanding their product lines to meet the diverse needs of diabetes patients. Market share is influenced by factors such as product innovation, ease of use, accessibility, and insurance coverage. Major players such as Novo Nordisk, Sanofi, and Eli Lilly dominate the market due to their extensive product ranges, global presence, and strong brand recognition. However, smaller companies and startups are also making significant inroads by focusing on niche segments, such as wearable insulin delivery devices and smart insulin pens, challenging the dominance of established players.

Key Insulin Delivery Devices Companies:

The following are the leading companies in the insulin delivery devices market. These companies collectively hold the largest market share and dictate industry trends.

Novo Nordisk A/S

Sanofi

Eli Lilly and Company

Ypsomed AG

Medtronic

Insulet Corporation

B. Braun SE

Owen Mumford Ltd.

Tandem Diabetes Care, Inc.

BD (Becton, Dickinson, and Company)

Recent Developments

In August 2023, Novo Nordisk A/S and Inversago Pharma have reached an agreement wherein Novo Nordisk will acquire Inversago for a sum that could reach up to 1.075 billion US dollars in cash, contingent upon the fulfillment of specific development and commercial benchmarks. Based in Montreal, Inversago Pharma is a privately held company specializing in the development of therapies targeting the CB1 receptor aimed at potentially treating obesity, diabetes, and related metabolic disorder complications.

In March 2023, Diabeloop, a forefront company in Automated Insulin Delivery technology, announced a partnership with the renowned healthcare giant, Novo Nordisk. This collaboration focuses on the integration of Diabeloop's advanced self-learning algorithm, DBL-4pen, specifically designed for Multiple Daily Injections (MDI) therapy, with Novo Nordisk's innovative, connected, and reusable insulin pens, namely NovoPen 6 and NovoPen Echo Plus. To assess the effectiveness and clinical advantages of this integrated solution, Diabeloop is gearing up to conduct a specialized study aimed at individuals diagnosed with Type 2 diabetes.

Sanofi announced a significant reduction in the list price for its widely used insulin product, Lantus (insulin glargine injection) 100 Units/mL, in the U.S., slashing it by 78%. In addition, the company introduced a cap of $35 on out-of-pocket expenses for all commercially insured patients needing Lantus, highlighting its ongoing dedication to making medications more affordable. These actions, effective from January 1, 2024, build upon earlier measures from June 2022 aimed at reducing the cost of diabetes medications. These included releasing a non-branded version of Lantus at 60% below its list price and implementing a $35 maximum on the out-of-pocket costs for insulin for individuals without insurance. Thanks to these comprehensive efforts, Sanofi has ensured that patients will not spend over $35 for a month's supply of Lantus. In a further step, Sanofi also announced a 70% reduction in the list price of its short-acting insulin, Apidra (insulin glulisine injection) 100 Units/mL.

In November 2022, Novo Nordisk and Abbott announced their partnership aiming enhanced data integration capabilities for individuals with diabetes. This development leverages smart technology by making Novo Nordisk's connected insulin pens, specifically the NovoPen 6 and NovoPen Echo Plus, compatible with the Abbott FreeStyle LibreLink application. This compatibility facilitates a centralized view of insulin dosage and glucose levels, streamlining patient monitoring and management. Users can effortlessly sync their insulin dosing information by simply tapping their pen on a smartphone, enabling a cohesive display of insulin and glucose data. This integration aims to aid patients in analyzing how insulin dosage adjustments and timing influence their glucose trends, thereby optimizing diabetes management.

Order a free sample PDF of the Insulin Delivery Devices Market Intelligence Study, published by Grand View Research.

[trendtrackershq]

Asia-Pacific: A Rising Giant - Poised for Dominance in the Point-of-Care Glucose Testing Market by 2030

Introduction:

The Point-of-Care Glucose Testing Market is experiencing a global surge, driven by the rising diabetes epidemic and the increasing demand for convenient and self-monitoring blood sugar management tools. While North America currently holds the dominant market share, the Asia-Pacific (APAC) region is emerging as a strong contender, poised for significant growth in the coming years.

Download FREE Sample: https://www.nextmsc.com/point-of-care-glucose-testing-market/request-sample

A Growing Diabetes Burden: Fueling Demand for POC Testing

The APAC region faces a significant challenge with a rapidly rising diabetes burden. According to the International Diabetes Federation (IDF), the APAC region is home to over half of the world's diabetic population, with China and India leading the charge [Source 2]. This alarming statistic underscores the urgent need for accessible and efficient blood sugar monitoring solutions, making POC glucose testing devices highly sought-after in the region.

Factors Driving Growth in the APAC POC Glucose Testing Market:

Several key factors are contributing to the exponential growth of the APAC POC glucose testing market:

Rising Disposable Incomes and Growing Awareness: The economic growth witnessed in several APAC countries is leading to increased disposable incomes. This, coupled with growing awareness about diabetes and its management, is creating a favorable environment for the adoption of POC glucose testing devices.

Expanding Healthcare Infrastructure and Government Initiatives: Governments in the APAC region are making significant investments in expanding healthcare infrastructure, particularly in rural and remote areas. Additionally, several governments are implementing initiatives to promote diabetes screening and early detection. These initiatives often include promoting the use of POC glucose testing devices for effective self-monitoring.

Focus on Affordable and Accessible Technologies: Manufacturers are increasingly developing cost-effective POC glucose testing devices specifically tailored for the needs of the APAC market. This focus on affordability, alongside initiatives promoting access to these devices, is crucial for reaching a wider population in the region.

Technological Advancements and Mobile Health Integration: The APAC region is witnessing a rapid rise in mobile phone adoption and internet penetration. This opens doors for the integration of POC glucose testing devices with mobile health (mHealth) applications. These apps allow for data tracking, analysis, and remote consultations with healthcare providers, further enhancing the appeal and effectiveness of POC testing in the region.

Rise of Big Data and Analytics:  The vast amount of data generated by POC glucose testing devices, coupled with big data analytics, can provide valuable insights into diabetes trends and personalized treatment plans. This trend is likely to drive the adoption of POC devices with data connectivity capabilities in the APAC region.

Focus on Artificial Intelligence (AI) Integration:  Advancements in AI hold immense potential for the POC glucose testing market. AI-powered algorithms can analyze blood sugar data and identify trends, predict potential complications, and even offer personalized recommendations for diabetes management. This integration of AI with POC devices is expected to gain traction in the APAC region.

Growing Telehealth Adoption:  The APAC region is witnessing a surge in telehealth adoption, driven by factors like increasing internet penetration and a shortage of healthcare professionals, particularly in rural areas. POC glucose testing devices that seamlessly integrate with telehealth platforms can empower patients in remote locations to receive timely consultations and guidance from healthcare providers.

Emphasis on Preventative Healthcare:  The growing awareness of the long-term complications associated with diabetes is shifting the focus towards preventative healthcare in the APAC region. POC glucose testing devices play a crucial role in enabling early detection of diabetes and promoting self-management practices, contributing to a preventative healthcare approach.

Challenges and Opportunities in the APAC Market:

Despite its immense potential, the APAC POC glucose testing market faces some challenges:

Uneven Healthcare Infrastructure: Healthcare infrastructure development varies considerably across the APAC region. While some countries boast advanced medical facilities, others struggle with limited resources and accessibility, particularly in rural areas. Addressing this disparity is crucial for ensuring equitable access to POC testing devices.

Limited Reimbursement Policies: Reimbursement policies for POC glucose testing devices can be complex and vary depending on individual countries and healthcare providers. Streamlining these policies could significantly increase patient access to these devices.

Inquire before buying: https://www.nextmsc.com/point-of-care-glucose-testing-market/inquire-before-buying

Looking Ahead: A Future of Innovation and Accessibility

The APAC region is on track to become a dominant force in the POC glucose testing market. With its large and growing diabetic population, rising disposable incomes, and increasing government support, the demand for these devices is expected to surge in the coming years. However, addressing the challenges of uneven healthcare infrastructure and limited reimbursement is crucial for ensuring equitable access and maximizing the impact of POC testing in the region. By fostering innovation in affordable and accessible technologies, coupled with improved healthcare infrastructure and supportive policies, the APAC region can leverage POC glucose testing devices to empower patients with diabetes and achieve better health outcomes.

Conclusion:

The APAC region stands poised to become a leader in the global point-of-care glucose testing market. Driven by a rapidly rising diabetic population, increasing disposable incomes, and supportive government initiatives, the demand for these devices is projected to soar. Several factors contribute to this growth, including a focus on affordable and accessible technologies, the integration with mobile health (mHealth) applications, and the rise of big data and AI for personalized diabetes management. Furthermore, the growing adoption of telehealth and the emphasis on preventative healthcare in the APAC region further incentivize the use of POC glucose testing devices. However, challenges remain. Uneven healthcare infrastructure and limited reimbursement policies can create barriers to access, particularly in rural areas. Addressing these disparities is crucial for maximizing the impact of POC testing and ensuring equitable access for all.

[themarketupdate]

Blood Sugar Monitor Market Growing Popularity and Emerging Trends in the Industry

Diabetic patients may use blood sugar monitoring to make regular maintenance choices including food consumption, insulin dosage, and physical activity. Patients use blood glucose metres to check their glucose levels quickly and provide an accurate measure of capillary glucose concentration. Self-monitoring blood sugar monitoring is a modern diabetes treatment technique that requires the use of blood glucose metres by patients to check their glucose levels quickly and provide an accurate measure of capillary glucose concentration. To maintain long-term glycemic control, the technology employs test strips, lancets, and blood glucose metres.The increase can be due to factors such as an increase in diabetes incidence rates and an increase in diabetes risk factors. Furthermore, technological advances in the field of blood glucose monitoring systems, as well as an increase in the geriatric population, are driving the demand for self-monitoring blood glucose devices. In the near future, high growth potential in untapped markets for diabetes monitoring devices is projected to provide lucrative opportunities for the global market for monitoring blood glucose devices.

Free Sample Report + All Related Graphs & Charts @: https://www.advancemarketanalytics.com/sample-report/79613-global-blood-sugar-monitor-market?utm_source=Organic&utm_medium=Vinay

Latest released the research study on Global Blood Sugar Monitor Market, offers a detailed overview of the factors influencing the global business scope. Blood Sugar Monitor Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Blood Sugar Monitor The study covers emerging player’s data, including: competitive landscape, sales, revenue and global market share of top manufacturers are Roche (Switzerland), Abbott (United States), LifeScan(United States), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (United States), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (United States)

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Southeast Asia.

Contact Us:

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

sales@advancemarketanalytics.com

[renubresearch]

Self-Monitoring Blood Glucose Device Market will be US$ 21.05 Billion by 2032

The global self-monitoring blood glucose (SMBG) device market is expected to grow significantly over the next few years, driven by the increasing prevalence of diabetes and the need for effective diabetes management. Renub Research provides a comprehensive analysis of the SMBG device market, covering key aspects such as market size, growth drivers, and future outlook. Market Size and Growth The…

[harshnews]

Needle Free Blood Drawing Devices Market Size, Share, Demand, Future Growth, Challenges and Competitive Analysis

"Needle Free Blood Drawing Devices Market – Industry Trends and Forecast to 2028

Global Needle Free Blood Drawing Devices Market, By Product Type (Handheld Devices Wearable Devices), Technology Type (Venepunture, Touch Based), End Users (Hospitals, Research Organizations, Diagnostic Centers, Personal Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Access Full 350-page PDF Report @

**Segments**

- By Type: The needle-free blood drawing devices market can be segmented into vacuum-assisted devices, and spring-loaded devices. Vacuum-assisted devices utilize negative pressure to draw blood without a needle, while spring-loaded devices use a mechanism that springs forward to create a puncture for blood collection.

- By Application: This market segment includes segments such as routine blood tests, glucose monitoring, coagulation testing, and other medical procedures that require blood samples. The needle-free blood drawing devices are designed to cater to various medical applications, thus enhancing their market penetration and growth potential.

- By End User: The end-user segments for needle-free blood drawing devices encompass hospitals & clinics, diagnostic centers, blood donation camps, and home healthcare settings. Each of these end-user segments has a specific demand for blood drawing devices based on their unique requirements and patient volumes.

**Market Players**

- Velano Vascular: Velano Vascular is a prominent player in the needle-free blood drawing devices market known for its innovative technology in blood collection. Their PIVO device allows for needle-free blood draws, enhancing patient comfort and safety.

- Seventh Sense Biosystems: Seventh Sense Biosystems offers TAP, a needle-free blood collection device that simplifies the blood drawing process and improves patient experience. Their device is user-friendly and accurate, making it a preferred choice in the market.

- Tasso Inc.: Tasso Inc. specializes in self-administered, pain-free blood sampling technology. Their HemoLink device collects blood samples without needles, catering to the growing demand for patient-centric blood collection solutions.

- Zipline Medical: Zipline Medical is known for its Zip-Stitch product, which provides needle-free wound closure solutions. While not directly related to blood drawing, Zipline Medical's innovative approach to needle-free procedures showcases the potential for growth and expansion in the medical device market.

The needle-free blood drawing devices market is witnessing significant growth due to the increasing focus on patient comfort, safety, and convenience. WithThe needle-free blood drawing devices market is experiencing rapid growth driven by the rising emphasis on enhancing patient comfort, safety, and convenience during blood collection procedures. The segmentation of the market into vacuum-assisted devices and spring-loaded devices offers a diverse range of options for healthcare providers to choose from based on their specific requirements. Vacuum-assisted devices leverage negative pressure technology to extract blood without a needle, while spring-loaded devices use a mechanical spring mechanism to create a puncture for blood sampling. This segmentation allows for flexibility in catering to different preferences and use cases within the medical field.

In terms of applications, needle-free blood drawing devices find utility in a variety of medical procedures such as routine blood tests, glucose monitoring, coagulation testing, and other diagnostic procedures that necessitate blood samples. The versatility of these devices in catering to multiple medical applications enhances their market acceptance and growth potential. Healthcare providers can benefit from the convenience and efficiency offered by needle-free blood drawing devices across various medical settings including hospitals & clinics, diagnostic centers, blood donation camps, and even home healthcare environments. Each end-user segment has distinct requirements and patient volumes, influencing the demand for specific types of blood drawing devices.

Several key market players are spearheading innovation in the needle-free blood drawing devices industry. Companies like Velano Vascular, Seventh Sense Biosystems, Tasso Inc., and Zipline Medical are at the forefront of developing cutting-edge technologies that improve blood collection processes and enhance patient experience. Velano Vascular's PIVO device, Seventh Sense Biosystems' TAP device, and Tasso Inc.'s HemoLink technology are all examples of innovative solutions that prioritize patient comfort and ease of use. While Zipline Medical's Zip-Stitch product focuses on needle-free wound closure solutions, it exemplifies the broader trend towards minimizing invasive procedures in the healthcare sector.

The market for needle-free blood drawing devices is projected to continue its upward trajectory as healthcare providers increasingly prioritize patient-centric care and seek innovative solutions to streamline clinical procedures. The demand for**Segments:**

- By Product Type: The needle-free blood drawing devices market can be categorized into handheld devices and wearable devices. Handheld devices are portable, user-friendly tools that offer flexibility in blood collection, while wearable devices are worn on the body and provide continuous monitoring capabilities. - By Technology Type: The market can be segmented based on technology type into venipuncture and touch-based technologies. Venipuncture devices mimic traditional blood drawing methods without the need for needles, while touch-based technologies utilize non-invasive techniques for blood sample collection. - By End Users: End users of needle-free blood drawing devices include hospitals, research organizations, diagnostic centers, personal clinics, and other healthcare facilities. Each end user has specific requirements for blood collection devices, influencing market demand and adoption rates.

Global Needle-Free Blood Drawing Devices Market Analysis:

The global needle-free blood drawing devices market is poised for substantial growth due to the increasing emphasis on patient comfort, safety, and efficiency in medical procedures. Handheld devices and wearable technologies offer healthcare providers diverse options to cater to individual patient needs and preferences. The advancement of venipuncture and touch-based technologies provides healthcare professionals with innovative tools to streamline blood collection processes and improve overall patient experience.

The market segmentation based on end users highlights the widespread adoption of needle-free blood drawing devices across various healthcare settings, including hospitals, research organizations, diagnostic centers, and personal clinics. These end users have distinct requirements for blood collection devices, driving market trends towards customization and specialization to meet specific demands.

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Needle Free Blood Drawing Devices Market Landscape

Part 04: Global Needle Free Blood Drawing Devices Market Sizing

Part 05: Global Needle Free Blood Drawing Devices Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Objectives of the Report

To carefully analyze and forecast the size of the Needle Free Blood Drawing Devices market by value and volume.

To estimate the market shares of major segments of the Needle Free Blood Drawing Devices

To showcase the development of the Needle Free Blood Drawing Devices market in different parts of the world.

To analyze and study micro-markets in terms of their contributions to the Needle Free Blood Drawing Devices market, their prospects, and individual growth trends.

To offer precise and useful details about factors affecting the growth of the Needle Free Blood Drawing Devices

To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Needle Free Blood Drawing Devices market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Key questions answered

How feasible is Needle Free Blood Drawing Devices Market for long-term investment?

What are influencing factors driving the demand for Needle Free Blood Drawing Devices near future?

What is the impact analysis of various factors in the Global Needle Free Blood Drawing Devices market growth?

What are the recent trends in the regional market and how successful they are?

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America

Browse Trending Reports:

Threat Detection Systems Market Pipe Coating Market Fragrance Fixatives Market Mobile Campaign Management Platform Market Menstrual Cramps Treatment Market Roof Insulation Market Mobile Robotics Market Varnish Makers Market Urinary Incontinence Market Treatment Resistant Depression Market Robotic Prosthetics Market Neutropenia Market Polycystic Kidney Disease Adpkd Market Grain Analysis Market Solid State Solar Cell Market Panel Mount Industrial Display Market Automotive Mini Led Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[omkarpatel]

Diabetes Injection Pens Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes

Diabetes injection pens are medical devices used for injecting insulin doses subcutaneously. Insulin pens combine an insulin cartridge with a dial to measure dosage and allows for hassle-free and accurate dose dispensing.

Market Dynamics:

The Diabetes Injection Pens Market is expected to witness significant growth over the forecast period owing to the increasing prevalence of diabetes across the globe. According to International Diabetes Federation, around 700 million people will be living with diabetes by 2045. Moreover, injection pens offer greater convenience and accuracy compared to vial and syringes, which also contributes to the growth of the market. Another major driver is the growing preference for human insulin analog over traditional human insulin due to similar glucose level control and lesser incidence of hypoglycemia.

Major Market Drivers - Adoption of Self-Care Practices For Diabetes Management

The rising prevalence of diabetes globally has necessitated the adoption of self-care practices for effective diabetes management. Self-monitoring of blood glucose levels using injection pens has become a vital practice among diabetics to help control blood sugar levels. Easy to use and store diabetes injection pens have enabled patients to self-administer insulin doses with high precision conveniently. As diabetes self-management gains more recognition as an important component of overall treatment, demand for diabetes injection pens is growing steadily.

Increasing Diabetes Incidence Due to Lifestyle Changes and Obesity

Changes in lifestyle and eating habits along with rising obesity rates have significantly contributed to the increasing incidence of diabetes worldwide. According to the International Diabetes Federation, about 463 million adults were living with diabetes in 2019 with the numbers projected to rise to 700 million by 2045. Most of the increase will occur in low and middle-income countries. As diabetes prevalence continues surging, especially in developing nations undergoing nutrition transition, usage of diabetes injection pens for effective therapy management is amplifying.

Major Market Restrain - High Cost of Branded Injection Pens

The high cost of technologically advanced branded insulin injection pens remains a major barrier hampering their widespread adoption, especially in cost-sensitive developing markets. While generic variants offer similar functionality at lower prices, branded pens still command a major share of the market due to physician preference and patient trust in established brands. However, patent expiries of blockbuster insulin brands in the coming years may help reduce prices through increased competition and availability of affordable biosimilar products. This can spur the diabetes injection pens market growth.

Major Market Opportunity - Untapped Potential in Developing Regions

Most of the future increase in the global diabetes population will occur in developing countries that are currently undergoing nutrition and lifestyle transition. While adoption of injection pens is gradually rising even in lower income settings, significant opportunities still remain untapped in these underpenetrated yet fast-growing diabetes markets. Increased awareness campaigns, expanded healthcare coverage and promotion of affordable generic devices can help boost injection pen usage, especially in Asia Pacific and Latin American countries where the economic burden of diabetes is rising sharply.

Major Market Trend - Connected Smart Pens With Digital Integration

One of the key trends emerging in the diabetes injection pens market is the introduction of ‘smart’ connected pens that can digitally store dosing history, integrate with mobile apps and cloud services. This allows remote monitoring by caregivers and physicians for better therapy management. Advanced features like Bluetooth connectivity, automatic log updates and customizable alerts are making connected pens more convenient to use. As digital health sees rapid innovation and adoption, smart pens equipped with such technologies are expected to gain prominence in the future to improve diabetes care outcomes.